Article thumbnail

Methylation and Loss of Secreted Frizzled-Related Protein 3 Enhances Melanoma Cell Migration and Invasion

By Elin J. Ekström, Victoria Sherwood and Tommy Andersson
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3072980
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). A Wnt survival guide: from flies to human disease.
  2. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
  3. (2009). Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.
  4. (2010). An updated overview on Wnt signaling pathways: a prelude for more.
  5. (2003). Beta-catenin in the melanocyte lineage.
  6. (2008). Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease.
  7. (2006). Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
  8. (2008). Coordinated molecular control of otic capsule differentiation: functional role of Wnt5a signaling and opposition by sfrp3 activity.
  9. (2009). CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma.
  10. (2002). Disulfide bond assignments of secreted Frizzled-related protein-1 provide insights about Frizzled homology and netrin modules.
  11. (2004). Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.
  12. (2005). Expression of Frzb/ secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness.
  13. (2004). Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma.
  14. (2002). Focus on melanoma.
  15. (2008). Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer.
  16. (1997). Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8.
  17. (2008). Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling.
  18. (2002). Gene Expression Omnibus: NCBI gene expression and hybridization array data repository.
  19. (2009). Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt.
  20. (2010). Identification of methylated genes associated with aggressive bladder cancer.
  21. (2001). Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains.
  22. (2002). Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas.
  23. (2002). MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427–1431. SFRP3 and Wnt5a-Dependent Melanoma Cell Migration PLoS
  24. (2005). Novel genes associated with malignant melanoma but not benign melanocytic lesions.
  25. (2006). Purified Wnt5a protein activates or inhibits betacatenin-TCF signaling depending on receptor context.
  26. (2007). Roles of secreted frizzled-related proteins in cancer.
  27. (2009). Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling.
  28. (2002). Secreted Frizzled-related proteins: searching for relationships and patterns.
  29. (2007). Severe suppression of Frzb/sFRP3 transcription in osteogenic sarcoma.
  30. (2005). SFRP1 regulates the growth of retinal ganglion cell axons through the Fz2 receptor.
  31. (2002). The human genome browser at UCSC.
  32. (1999). The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases.
  33. (2009). The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
  34. (2010). The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma.
  35. (2006). The WNT/Beta-catenin pathway in melanoma.
  36. (2007). The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
  37. (2005). Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas.
  38. (2006). Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells.
  39. (2008). WNT5A expression increases during melanoma progression and correlates with outcome.
  40. (2007). Wnt5a functions in planar cell polarity regulation in mice.
  41. (2008). Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation.
  42. (2002). Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
  43. (2003). Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements.